Previous Close | 0.0900 |
Open | 0.1500 |
Bid | 0.0800 |
Ask | 0.2300 |
Strike | 250.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.1200 - 0.4000 |
Contract Range | N/A |
Volume | |
Open Interest | 612 |
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackJudge Threatens Trump With Jail Over Gag Order ViolationsAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeTreasury Rally Risks Running Into a $125 Billion Brick WallBuffett Praises Apple After Trimming It, Drops Paramount StakeThe shares s
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats